gl 331 has been researched along with Stomach Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, JY; Chao, Y; Chen, JD; Chen, LT; Lan, C; Li, AF; Lin, WC; Liu, JM; Liu, TS; Shiah, HS; Whang-Peng, J; Wu, CW; Wu, HW | 1 |
1 trial(s) available for gl 331 and Stomach Neoplasms
Article | Year |
---|---|
Phase II and pharmacokinetic study of GL331 in previously treated Chinese gastric cancer patients.
Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Female; Follow-Up Studies; Humans; Immunohistochemistry; Male; Middle Aged; Stomach Neoplasms; Survival Analysis | 2002 |